Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Comparison of three office blood pressure measurement techniques and their effect on hypertension prevalence in the general population.

Wohlfahrt P, Cífková R, Krajčoviechová A, Šulc P, Bruthans J, Linhart A, Filipovský J, Mayer O, Widimský J Jr.

J Hypertens. 2019 Dec 12. doi: 10.1097/HJH.0000000000002322. [Epub ahead of print]

PMID:
31834128
2.

Normative reference ranges for echocardiographic chamber dimensions in a healthy Central European population: results from the Czech post-MONICA survey.

Marek J, Lubanda JC, Cifkova R, Kuchynka P, Golan L, Nemcek E, Linhart A.

Cardiovasc Ultrasound. 2019 Oct 30;17(1):22. doi: 10.1186/s12947-019-0172-0.

3.

Soluble receptor for advanced glycation end-products independently influences individual age-dependent increase of arterial stiffness.

Gelžinský J, Mayer O Jr, Seidlerová J, Mateřánková M, Mareš Š, Kordíková V, Trefil L, Cífková R, Filipovský J.

Hypertens Res. 2019 Oct 21. doi: 10.1038/s41440-019-0347-y. [Epub ahead of print]

PMID:
31636359
4.

Target genes, variants, tissues and transcriptional pathways influencing human serum urate levels.

Tin A, Marten J, Halperin Kuhns VL, Li Y, Wuttke M, Kirsten H, Sieber KB, Qiu C, Gorski M, Yu Z, Giri A, Sveinbjornsson G, Li M, Chu AY, Hoppmann A, O'Connor LJ, Prins B, Nutile T, Noce D, Akiyama M, Cocca M, Ghasemi S, van der Most PJ, Horn K, Xu Y, Fuchsberger C, Sedaghat S, Afaq S, Amin N, Ärnlöv J, Bakker SJL, Bansal N, Baptista D, Bergmann S, Biggs ML, Biino G, Boerwinkle E, Bottinger EP, Boutin TS, Brumat M, Burkhardt R, Campana E, Campbell A, Campbell H, Carroll RJ, Catamo E, Chambers JC, Ciullo M, Concas MP, Coresh J, Corre T, Cusi D, Felicita SC, de Borst MH, De Grandi A, de Mutsert R, de Vries APJ, Delgado G, Demirkan A, Devuyst O, Dittrich K, Eckardt KU, Ehret G, Endlich K, Evans MK, Gansevoort RT, Gasparini P, Giedraitis V, Gieger C, Girotto G, Gögele M, Gordon SD, Gudbjartsson DF, Gudnason V; German Chronic Kidney Disease Study, Haller T, Hamet P, Harris TB, Hayward C, Hicks AA, Hofer E, Holm H, Huang W, Hutri-Kähönen N, Hwang SJ, Ikram MA, Lewis RM, Ingelsson E, Jakobsdottir J, Jonsdottir I, Jonsson H, Joshi PK, Josyula NS, Jung B, Kähönen M, Kamatani Y, Kanai M, Kerr SM, Kiess W, Kleber ME, Koenig W, Kooner JS, Körner A, Kovacs P, Krämer BK, Kronenberg F, Kubo M, Kühnel B, La Bianca M, Lange LA, Lehne B, Lehtimäki T; Lifelines Cohort Study, Liu J, Loeffler M, Loos RJF, Lyytikäinen LP, Magi R, Mahajan A, Martin NG, März W, Mascalzoni D, Matsuda K, Meisinger C, Meitinger T, Metspalu A, Milaneschi Y; V. A. Million Veteran Program, O'Donnell CJ, Wilson OD, Gaziano JM, Mishra PP, Mohlke KL, Mononen N, Montgomery GW, Mook-Kanamori DO, Müller-Nurasyid M, Nadkarni GN, Nalls MA, Nauck M, Nikus K, Ning B, Nolte IM, Noordam R, O'Connell JR, Olafsson I, Padmanabhan S, Penninx BWJH, Perls T, Peters A, Pirastu M, Pirastu N, Pistis G, Polasek O, Ponte B, Porteous DJ, Poulain T, Preuss MH, Rabelink TJ, Raffield LM, Raitakari OT, Rettig R, Rheinberger M, Rice KM, Rizzi F, Robino A, Rudan I, Krajcoviechova A, Cifkova R, Rueedi R, Ruggiero D, Ryan KA, Saba Y, Salvi E, Schmidt H, Schmidt R, Shaffer CM, Smith AV, Smith BH, Spracklen CN, Strauch K, Stumvoll M, Sulem P, Tajuddin SM, Teren A, Thiery J, Thio CHL, Thorsteinsdottir U, Toniolo D, Tönjes A, Tremblay J, Uitterlinden AG, Vaccargiu S, van der Harst P, van Duijn CM, Verweij N, Völker U, Vollenweider P, Waeber G, Waldenberger M, Whitfield JB, Wild SH, Wilson JF, Yang Q, Zhang W, Zonderman AB, Bochud M, Wilson JG, Pendergrass SA, Ho K, Parsa A, Pramstaller PP, Psaty BM, Böger CA, Snieder H, Butterworth AS, Okada Y, Edwards TL, Stefansson K, Susztak K, Scholz M, Heid IM, Hung AM, Teumer A, Pattaro C, Woodward OM, Vitart V, Köttgen A.

Nat Genet. 2019 Oct;51(10):1459-1474. doi: 10.1038/s41588-019-0504-x. Epub 2019 Oct 2.

PMID:
31578528
5.

Mood disorders impaired quality of life but not the mortality or morbidity risk in stable coronary heart disease patients.

Mayer O Jr, Bruthans J, Seidlerová J, Karnosová P, Mateřánková M, Gelžinský J, Rychecká M, Cífková R, Filipovský J.

Acta Cardiol. 2019 Aug 23:1-9. doi: 10.1080/00015385.2019.1653568. [Epub ahead of print]

PMID:
31442189
6.

Blood pressure distribution and control in coronary patients from 24 European countries in the European Society of Cardiology EURoObservational Research Programme European survey of cardiovascular disease prevention and diabetes. EUROASPIRE IV Registry.

Cífková R, Lánská V, Bruthans J, Mayer O Jr, Kotseva K, Wood D, Lovic D, De Sutter J, Reiner Z, Fras Z, Deckers J, Gotcheva N, Georgiev B, De Bacquer D; EUROASPIRE IV investigators.

J Hypertens. 2019 Oct;37(10):2015-2023. doi: 10.1097/HJH.0000000000002130.

PMID:
31246889
7.

A catalog of genetic loci associated with kidney function from analyses of a million individuals.

Wuttke M, Li Y, Li M, Sieber KB, Feitosa MF, Gorski M, Tin A, Wang L, Chu AY, Hoppmann A, Kirsten H, Giri A, Chai JF, Sveinbjornsson G, Tayo BO, Nutile T, Fuchsberger C, Marten J, Cocca M, Ghasemi S, Xu Y, Horn K, Noce D, van der Most PJ, Sedaghat S, Yu Z, Akiyama M, Afaq S, Ahluwalia TS, Almgren P, Amin N, Ärnlöv J, Bakker SJL, Bansal N, Baptista D, Bergmann S, Biggs ML, Biino G, Boehnke M, Boerwinkle E, Boissel M, Bottinger EP, Boutin TS, Brenner H, Brumat M, Burkhardt R, Butterworth AS, Campana E, Campbell A, Campbell H, Canouil M, Carroll RJ, Catamo E, Chambers JC, Chee ML, Chee ML, Chen X, Cheng CY, Cheng Y, Christensen K, Cifkova R, Ciullo M, Concas MP, Cook JP, Coresh J, Corre T, Sala CF, Cusi D, Danesh J, Daw EW, de Borst MH, De Grandi A, de Mutsert R, de Vries APJ, Degenhardt F, Delgado G, Demirkan A, Di Angelantonio E, Dittrich K, Divers J, Dorajoo R, Eckardt KU, Ehret G, Elliott P, Endlich K, Evans MK, Felix JF, Foo VHX, Franco OH, Franke A, Freedman BI, Freitag-Wolf S, Friedlander Y, Froguel P, Gansevoort RT, Gao H, Gasparini P, Gaziano JM, Giedraitis V, Gieger C, Girotto G, Giulianini F, Gögele M, Gordon SD, Gudbjartsson DF, Gudnason V, Haller T, Hamet P, Harris TB, Hartman CA, Hayward C, Hellwege JN, Heng CK, Hicks AA, Hofer E, Huang W, Hutri-Kähönen N, Hwang SJ, Ikram MA, Indridason OS, Ingelsson E, Ising M, Jaddoe VWV, Jakobsdottir J, Jonas JB, Joshi PK, Josyula NS, Jung B, Kähönen M, Kamatani Y, Kammerer CM, Kanai M, Kastarinen M, Kerr SM, Khor CC, Kiess W, Kleber ME, Koenig W, Kooner JS, Körner A, Kovacs P, Kraja AT, Krajcoviechova A, Kramer H, Krämer BK, Kronenberg F, Kubo M, Kühnel B, Kuokkanen M, Kuusisto J, La Bianca M, Laakso M, Lange LA, Langefeld CD, Lee JJ, Lehne B, Lehtimäki T, Lieb W; Lifelines Cohort Study, Lim SC, Lind L, Lindgren CM, Liu J, Liu J, Loeffler M, Loos RJF, Lucae S, Lukas MA, Lyytikäinen LP, Mägi R, Magnusson PKE, Mahajan A, Martin NG, Martins J, März W, Mascalzoni D, Matsuda K, Meisinger C, Meitinger T, Melander O, Metspalu A, Mikaelsdottir EK, Milaneschi Y, Miliku K, Mishra PP; V. A. Million Veteran Program, Mohlke KL, Mononen N, Montgomery GW, Mook-Kanamori DO, Mychaleckyj JC, Nadkarni GN, Nalls MA, Nauck M, Nikus K, Ning B, Nolte IM, Noordam R, O'Connell J, O'Donoghue ML, Olafsson I, Oldehinkel AJ, Orho-Melander M, Ouwehand WH, Padmanabhan S, Palmer ND, Palsson R, Penninx BWJH, Perls T, Perola M, Pirastu M, Pirastu N, Pistis G, Podgornaia AI, Polasek O, Ponte B, Porteous DJ, Poulain T, Pramstaller PP, Preuss MH, Prins BP, Province MA, Rabelink TJ, Raffield LM, Raitakari OT, Reilly DF, Rettig R, Rheinberger M, Rice KM, Ridker PM, Rivadeneira F, Rizzi F, Roberts DJ, Robino A, Rossing P, Rudan I, Rueedi R, Ruggiero D, Ryan KA, Saba Y, Sabanayagam C, Salomaa V, Salvi E, Saum KU, Schmidt H, Schmidt R, Schöttker B, Schulz CA, Schupf N, Shaffer CM, Shi Y, Smith AV, Smith BH, Soranzo N, Spracklen CN, Strauch K, Stringham HM, Stumvoll M, Svensson PO, Szymczak S, Tai ES, Tajuddin SM, Tan NYQ, Taylor KD, Teren A, Tham YC, Thiery J, Thio CHL, Thomsen H, Thorleifsson G, Toniolo D, Tönjes A, Tremblay J, Tzoulaki I, Uitterlinden AG, Vaccargiu S, van Dam RM, van der Harst P, van Duijn CM, Velez Edward DR, Verweij N, Vogelezang S, Völker U, Vollenweider P, Waeber G, Waldenberger M, Wallentin L, Wang YX, Wang C, Waterworth DM, Bin Wei W, White H, Whitfield JB, Wild SH, Wilson JF, Wojczynski MK, Wong C, Wong TY, Xu L, Yang Q, Yasuda M, Yerges-Armstrong LM, Zhang W, Zonderman AB, Rotter JI, Bochud M, Psaty BM, Vitart V, Wilson JG, Dehghan A, Parsa A, Chasman DI, Ho K, Morris AP, Devuyst O, Akilesh S, Pendergrass SA, Sim X, Böger CA, Okada Y, Edwards TL, Snieder H, Stefansson K, Hung AM, Heid IM, Scholz M, Teumer A, Köttgen A, Pattaro C.

Nat Genet. 2019 Jun;51(6):957-972. doi: 10.1038/s41588-019-0407-x. Epub 2019 May 31.

8.

The low expression of circulating microRNA-19a represents an additional mortality risk in stable patients with vascular disease.

Mayer O Jr, Seidlerová J, Černá V, Kučerová A, Vaněk J, Karnosová P, Bruthans J, Wohlfahrt P, Cífková R, Pešta M, Filipovský J.

Int J Cardiol. 2019 Aug 15;289:101-106. doi: 10.1016/j.ijcard.2019.05.008. Epub 2019 May 6.

PMID:
31085080
9.

The prognostic importance of subclinical heart failure in stable coronary heart disease patients.

König P, Mayer O, Bruthans J, Seidlerová J, Mateřánková M, Gelžinský J, Rychecká M, Karnosová P, Wohlfahrt P, Cífková R, Filipovský J.

Acta Cardiol. 2019 Apr 3:1-8. doi: 10.1080/00015385.2019.1590958. [Epub ahead of print]

PMID:
30942129
10.

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomstrom-Lundqvist C, Cifkova R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA.

Kardiol Pol. 2019;77(3):245-326. doi: 10.5603/KP.2019.0049. No abstract available.

11.

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.

Kotseva K, De Backer G, De Bacquer D, Rydén L, Hoes A, Grobbee D, Maggioni A, Marques-Vidal P, Jennings C, Abreu A, Aguiar C, Badariene J, Bruthans J, Castro Conde A, Cifkova R, Crowley J, Davletov K, Deckers J, De Smedt D, De Sutter J, Dilic M, Dolzhenko M, Dzerve V, Erglis A, Fras Z, Gaita D, Gotcheva N, Heuschmann P, Hasan-Ali H, Jankowski P, Lalic N, Lehto S, Lovic D, Mancas S, Mellbin L, Milicic D, Mirrakhimov E, Oganov R, Pogosova N, Reiner Z, Stöerk S, Tokgözoğlu L, Tsioufis C, Vulic D, Wood D; EUROASPIRE Investigators*.

Eur J Prev Cardiol. 2019 May;26(8):824-835. doi: 10.1177/2047487318825350. Epub 2019 Feb 10.

12.

A summary of the EAS consensus concerning the causal relationship between low-density lipoproteins and atherosclerotic cardiovascular diseases, prepared by the Board of the Czech Society for Atherosclerosis.

Soška V, Karásek D, Bláha V, Cífková R, Freiberger T, Kraml P, Piťha J, Rosolová H, Štulc T, Urbanová Z, Vrablík M.

Vnitr Lek. Winter 2019;64(12):1124-1128.

PMID:
30704245
13.

Is the impact of conventional risk factors the same in men and women? Plea for a more gender-specific approach.

Cifkova R, Pitha J, Krajcoviechova A, Kralikova E.

Int J Cardiol. 2019 Jul 1;286:214-219. doi: 10.1016/j.ijcard.2019.01.039. Epub 2019 Jan 18.

PMID:
30685102
14.

Uromodulin in a Pathway Between Decreased Renal Urate Excretion and Albuminuria.

Krajcoviechova A, Marois-Blanchet FC, Troyanov S, Harvey F, Dumas P, Tremblay J, Cifkova R, Awadalla P, Madore F, Hamet P.

Am J Hypertens. 2019 Mar 16;32(4):384-392. doi: 10.1093/ajh/hpy190.

PMID:
30551216
15.

Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study.

De Bacquer D, De Smedt D, Kotseva K, Jennings C, Wood D, Rydén L, Gyberg V, Shahim B, Amouyel P, Bruthans J, Castro Conde A, Cífková R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pajak A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D, Wagner M, De Backer G; EUROASPIRE Investigators.

Eur J Epidemiol. 2019 Mar;34(3):247-258. doi: 10.1007/s10654-018-0454-0. Epub 2018 Oct 23.

16.

Cost-effectiveness of optimized adherence to prevention guidelines in European patients with coronary heart disease: Results from the EUROASPIRE IV survey.

De Smedt D, Annemans L, De Backer G, Kotseva K, Rydèn L, Wood D, Amouyel P, Bruthans J, Cifkova R, De Sutter J, Dolzhenko M, Erglis A, Gotcheva N, Gyberg V, Laucevicius A, Lovic D, Oganov R, Pajak A, Pogosova N, Reiner Ž, Stagmo M, De Bacquer D.

Int J Cardiol. 2018 Dec 1;272:20-25. doi: 10.1016/j.ijcard.2018.06.104. Epub 2018 Jun 28.

17.

2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340. No abstract available.

PMID:
30165544
18.

The Prognostic Importance of Impaired Fasting Glycemia in Chronic Coronary Heart Disease Patients.

Slezák D, Mayer O, Bruthans J, Seidlerová J, Rychecká M, Gelžinský J, Mateřánková M, Karnosová P, Wohlfahrt P, Cífková R, Filipovský J.

Exp Clin Endocrinol Diabetes. 2018 Aug 29. doi: 10.1055/a-0684-9601. [Epub ahead of print]

PMID:
30157533
19.

Cardiovascular Sequels of Hypertension in Pregnancy.

Cífková R.

J Am Heart Assoc. 2018 May 13;7(10). pii: e009300. doi: 10.1161/JAHA.118.009300. No abstract available.

20.

Hypertension.

Oparil S, Acelajado MC, Bakris GL, Berlowitz DR, Cífková R, Dominiczak AF, Grassi G, Jordan J, Poulter NR, Rodgers A, Whelton PK.

Nat Rev Dis Primers. 2018 Mar 22;4:18014. doi: 10.1038/nrdp.2018.14. Review.

21.

Left ventricular hypertrophy in females with hypertension is associated with a poor prognosis.

Cífková R.

Int J Cardiol. 2018 May 1;258:277-278. doi: 10.1016/j.ijcard.2018.01.092. No abstract available.

PMID:
29544943
22.

Serum Vitamin D Status, Vitamin D Receptor Polymorphism, and Glucose Homeostasis in Healthy Subjects.

Mayer O, Seidlerová J, Černá V, Kučerová A, Karnosová P, Hronová M, Wohlfahrt P, Fuchsová R, Filipovský J, Cífková R, Topolčan O, Pešta M.

Horm Metab Res. 2018 Jan;50(1):56-64. doi: 10.1055/s-0043-122144. Epub 2017 Nov 28.

PMID:
29183090
23.

Hypertensive complications of pregnancy: A clinical overview.

Antza C, Cifkova R, Kotsis V.

Metabolism. 2018 Sep;86:102-111. doi: 10.1016/j.metabol.2017.11.011. Epub 2017 Nov 21. Review.

PMID:
29169855
24.

Should 24-Hour Ambulatory Blood Pressure Monitoring Become Part of Regular Checkup in Women With Previous Preeclampsia?

Cífková R.

Hypertension. 2018 Jan;71(1):59-60. doi: 10.1161/HYPERTENSIONAHA.117.09915. Epub 2017 Nov 13. No abstract available.

PMID:
29133361
25.

Reply.

Mancia G, Coca A, Agabiti-Rosei E, Cifkova R, Manolis AJ, Redon J.

J Hypertens. 2017 Dec;35(12):2551-2552. doi: 10.1097/HJH.0000000000001580. No abstract available.

PMID:
29095235
26.

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.

Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group.

N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

27.

Kardiovize Brno 2030, a prospective cardiovascular health study in Central Europe: Methods, baseline findings and future directions.

Movsisyan NK, Vinciguerra M, Lopez-Jimenez F, Kunzová Š, Homolka M, Jaresova J, Cífková R, Sochor O.

Eur J Prev Cardiol. 2018 Jan;25(1):54-64. doi: 10.1177/2047487317726623. Epub 2017 Aug 16.

PMID:
28812915
28.

Prospective study of metabolic syndrome as a mortality marker in chronic coronary heart disease patients.

Mayer O Jr, Bruthans J, Seidlerová J, Karnosová P, Vaněk J, Hronová M, Gelžinský J, Cvíčela M, Wohlfahrt P, Cífková R, Filipovský J.

Eur J Intern Med. 2018 Jan;47:55-61. doi: 10.1016/j.ejim.2017.07.018. Epub 2017 Jul 26.

PMID:
28755847
29.

Reference values of cardio-ankle vascular index in a random sample of a white population.

Wohlfahrt P, Cífková R, Movsisyan N, Kunzová Š, Lešovský J, Homolka M, Soška V, Dobšák P, Lopez-Jimenez F, Sochor O.

J Hypertens. 2017 Nov;35(11):2238-2244. doi: 10.1097/HJH.0000000000001437.

PMID:
28594708
30.

Synergistic effect of low K and D vitamin status on arterial stiffness in a general population.

Mayer O Jr, Seidlerová J, Wohlfahrt P, Filipovský J, Cífková R, Černá V, Kučerová A, Pešta M, Fuchsová R, Topolčan O, Jardon KMC, Drummen NEA, Vermeer C.

J Nutr Biochem. 2017 Aug;46:83-89. doi: 10.1016/j.jnutbio.2017.04.010. Epub 2017 Apr 22.

PMID:
28486172
31.

The polypill in cardiovascular prevention: evidence, limitations and perspective - position paper of the European Society of Hypertension.

Coca A, Agabiti-Rosei E, Cifkova R, Manolis AJ, Redón J, Mancia G.

J Hypertens. 2017 Aug;35(8):1546-1553. doi: 10.1097/HJH.0000000000001390. Review.

PMID:
28448291
32.

Success and failure of cardiovascular disease prevention in Czech Republic over the past 30 years. Czech part of the EUROASPIRE I-IV surveys.

Rosolová H, Nussbaumerová B, Mayer O Jr, Cífková R, Bruthans J.

Physiol Res. 2017 Apr 5;66(Supplementum 1):S77-S84. Review.

33.

[Hypertension and hypercholesterolemia in the Czech population].

Wohlfahrt P, Krajčoviechová A, Bruthans J, Cífková R.

Vnitr Lek. Fall 2016;62(11):863-867. Czech.

PMID:
28128571
34.

Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys.

Ueda P, Woodward M, Lu Y, Hajifathalian K, Al-Wotayan R, Aguilar-Salinas CA, Ahmadvand A, Azizi F, Bentham J, Cifkova R, Di Cesare M, Eriksen L, Farzadfar F, Ferguson TS, Ikeda N, Khalili D, Khang YH, Lanska V, León-Muñoz L, Magliano DJ, Margozzini P, Msyamboza KP, Mutungi G, Oh K, Oum S, Rodríguez-Artalejo F, Rojas-Martinez R, Valdivia G, Wilks R, Shaw JE, Stevens GA, Tolstrup JS, Zhou B, Salomon JA, Ezzati M, Danaei G.

Lancet Diabetes Endocrinol. 2017 Mar;5(3):196-213. doi: 10.1016/S2213-8587(17)30015-3. Epub 2017 Jan 24.

35.

Response to Letter to the Editor entitled Oxidative Stress Participates in the Associations Between Serum Uric Acid and Albuminuria in Obesity.

Krajcoviechova A, Tremblay J, Wohlfahrt P, Bruthans J, Tahir MR, Hamet P, Cifkova R.

Am J Hypertens. 2017 Mar 1;30(3):e2-e3. doi: 10.1093/ajh/hpw198. No abstract available.

PMID:
28096151
36.

The Impact of Blood Pressure and Visceral Adiposity on the Association of Serum Uric Acid With Albuminuria in Adults Without Full Metabolic Syndrome.

Krajcoviechova A, Tremblay J, Wohlfahrt P, Bruthans J, Tahir MR, Hamet P, Cifkova R.

Am J Hypertens. 2016 Dec 1;29(12):1335-1342. doi: 10.1093/ajh/hpw098.

PMID:
27565787
37.

Threshold for diagnosing hypertension by automated office blood pressure using random sample population data.

Wohlfahrt P, Cífková R, Movsisyan N, Kunzová Š, Lešovský J, Homolka M, Soška V, Bauerová H, Lopez-Jimenez F, Sochor O.

J Hypertens. 2016 Nov;34(11):2180-6. doi: 10.1097/HJH.0000000000001076.

PMID:
27512968
38.

Current and past smoking patterns in a Central European urban population: a cross-sectional study in a high-burden country.

Movsisyan NK, Sochor O, Kralikova E, Cifkova R, Ross H, Lopez-Jimenez F.

BMC Public Health. 2016 Jul 15;16:571. doi: 10.1186/s12889-016-3216-5.

39.

Changes in Hypertension Prevalence, Awareness, Treatment, and Control in High-, Middle-, and Low-Income Countries: An Update.

Cifkova R, Fodor G, Wohlfahrt P.

Curr Hypertens Rep. 2016 Aug;18(8):62. doi: 10.1007/s11906-016-0669-y. Review.

PMID:
27372446
40.

[PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated?Czech atherosclerosis society statement].

Soška V, Vrablík M, Bláha V, Cífková R, Češka R, Freiberger T, Kraml P, Piťha J, Rosolová H, Štulc T, Vaverková H, Urbanová Z.

Vnitr Lek. 2016 Apr;62(4):329-33. Czech.

PMID:
27250613
41.

ESHRE Guideline: management of women with premature ovarian insufficiency.

European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI, Webber L, Davies M, Anderson R, Bartlett J, Braat D, Cartwright B, Cifkova R, de Muinck Keizer-Schrama S, Hogervorst E, Janse F, Liao L, Vlaisavljevic V, Zillikens C, Vermeulen N.

Hum Reprod. 2016 May;31(5):926-37. doi: 10.1093/humrep/dew027. Epub 2016 Mar 22.

PMID:
27008889
42.

A comparison of secondary prevention practice in poststroke and coronary heart disease patients.

Vaněk J, Mayer O Jr, Seidlerová J, Bruthans J, Kielbergerová L, Wohlfahrt P, Krajčoviechová A, Filipovský J, Cífková R.

Public Health. 2016 Aug;137:64-72. doi: 10.1016/j.puhe.2016.02.003. Epub 2016 Mar 17.

PMID:
26996311
43.

Time Trends in Lifestyle, Risk Factor Control, and Use of Evidence-Based Medications in Patients With Coronary Heart Disease in Europe: Results From 3 EUROASPIRE Surveys, 1999-2013.

Kotseva K, De Bacquer D, Jennings C, Gyberg V, De Backer G, Rydén L, Amouyel P, Bruthans J, Cifkova R, Deckers JW, De Sutter J, Fraz Z, Graham I, Keber I, Lehto S, Moore D, Pajak A, Wood D; EUROASPIRE Investigators.

Glob Heart. 2017 Dec;12(4):315-322.e3. doi: 10.1016/j.gheart.2015.11.003. Epub 2016 Mar 16.

44.

Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.

Zanchetti A, Liu L, Mancia G, Parati G, Grassi G, Stramba-Badiale M, Silani V, Bilo G, Corrao G, Zambon A, Scotti L, Zhang X, Guan TR, Zhang Y, Zhang X, Berge E, Redon J, Narkiewicz K, Dominiczak A, Nilsson P, Viigimaa M, Laurent S, Agabiti-Rosei E, Wu Z, Zhu D, Rodicio JL, Ruilope LM, Martell-Claros N, Pinto F, Schmieder RE, Burnier M, Banach M, Cifkova R, Farsang C, Konradi A, Lazareva I, Sirenko Y, Dorobantu M, Postadzhiyan A, Accetto R, Jelakovic B, Lovic D, Manolis AJ, Stylianou P, Dicker D, Wei G, Xu C, Xie H, Coca A, O'Brien J, Ford G; ESH-CHL-SHOT trial investigators.

J Hypertens. 2016 Mar;34(3):393-6. doi: 10.1097/HJH.0000000000000853. No abstract available.

PMID:
26780185
45.

Association of intima-media thickness of carotid arteries with remnant lipoproteins in men and women.

Piťha J, Kovář J, Škodová Z, Cífková R, Stávek P, Červenka L, Šejda T, Lánská V, Poledne R.

Physiol Res. 2015;64 Suppl 3:S377-84.

46.

Soluble receptor for advanced glycation end products and increased aortic stiffness in the general population.

Mayer O, Seidlerová J, Filipovský J, Vágovičová P, Wohlfahrt P, Cífková R, Windrichová J, Topolčan O.

Hypertens Res. 2016 Apr;39(4):266-71. doi: 10.1038/hr.2015.131. Epub 2015 Dec 3.

PMID:
26631850
47.

The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.

Mayer O Jr, Seidlerová J, Vaněk J, Karnosová P, Bruthans J, Filipovský J, Wohlfahrt P, Cífková R, Windrichová J, Knapen MH, Drummen NE, Vermeer C.

Int J Cardiol. 2016 Jan 15;203:916-22. doi: 10.1016/j.ijcard.2015.10.226. Epub 2015 Oct 31.

PMID:
26618253
48.

Adverse Lifestyle Trends Counter Improvements in Cardiovascular Risk Factor Management in Coronary Patients.

Kotseva K, De Bacquer D, Jennings C, Gyberg V, De Backer G, Rydén L, Amouyel P, Bruthans J, Cifkova R, Deckers JW, De Sutter J, Fraz Z, Graham I, Keber I, Lehto S, Moore D, Pajak A, Wood D; EUROASPIRE Investigators.

J Am Coll Cardiol. 2015 Oct 6;66(14):1634-1636. doi: 10.1016/j.jacc.2015.07.061. No abstract available. Erratum in: J Am Coll Cardiol. 2015 Nov 17;66(20):2270. Amouyel, Philippe [added].

49.

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.

Gyberg V, De Bacquer D, De Backer G, Jennings C, Kotseva K, Mellbin L, Schnell O, Tuomilehto J, Wood D, Rydén L, Amouyel P, Bruthans J, Conde AC, Cifkova R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pająk A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D; EUROASPIRE Investigators.

Cardiovasc Diabetol. 2015 Oct 1;14:133. doi: 10.1186/s12933-015-0296-y.

50.

The DRD2/ANKK1 Taq1A polymorphism is associated with smoking cessation failure in patients with coronary heart disease.

Mayer O Jr, Seidlerová J, Černá V, Kučerová A, Bruthans J, Vágovičová P, Vaněk J, Timoracká K, Wohlfahrt P, Filipovský J, Cífková R, Pešta M.

Per Med. 2015 Sep;12(5):463-473. doi: 10.2217/pme.15.16. Epub 2015 Oct 2.

PMID:
29749891

Supplemental Content

Loading ...
Support Center